|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the period ended January 31, 2005 | ||
| or | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
|
Massachusetts
|
04-2454372 | |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
8 Centennial Drive Peabody, Massachusetts (Address of principal executive offices) |
01960 (Zip Code) |
|
1
| Item 1. | Financial Statements |
| January 31, | July 31, | |||||||||
| 2005 | 2004 | |||||||||
| ASSETS | ||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 160,040 | $ | 149,549 | ||||||
|
Marketable securities, at fair value
|
65,460 | 27,088 | ||||||||
|
Accounts and notes receivable, net of allowance for doubtful
accounts of $2,473 at January 31, 2005 and $2,493 at
July 31, 2004
|
48,742 | 55,498 | ||||||||
|
Inventories
|
70,339 | 65,952 | ||||||||
|
Costs related to deferred revenue
|
13,857 | 12,723 | ||||||||
|
Refundable and deferred income taxes
|
| 10,861 | ||||||||
|
Other current assets
|
7,572 | 6,450 | ||||||||
|
Total current assets
|
366,010 | 328,121 | ||||||||
|
Property, plant and equipment, net
|
91,443 | 91,077 | ||||||||
|
Investments in and advances to affiliated companies
|
2,112 | 10,967 | ||||||||
|
Capitalized software, net
|
12,217 | 9,502 | ||||||||
|
Goodwill
|
1,623 | 1,565 | ||||||||
|
Intangible assets, net
|
7,869 | 9,223 | ||||||||
|
Costs related to deferred revenue
|
219 | 219 | ||||||||
|
Other assets
|
3,898 | 1,397 | ||||||||
|
Total Assets
|
$ | 485,391 | $ | 452,071 | ||||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
|
Current liabilities:
|
||||||||||
|
Notes payable
|
$ | 42 | $ | 785 | ||||||
|
Obligations under capital leases
|
165 | 177 | ||||||||
|
Accounts payable, trade
|
22,274 | 21,707 | ||||||||
|
Accrued liabilities
|
20,264 | 21,380 | ||||||||
|
Deferred revenue
|
28,346 | 26,281 | ||||||||
|
Advance payments
|
11,976 | 6,125 | ||||||||
|
Accrued income taxes
|
2,876 | 5,791 | ||||||||
|
Deferred income taxes
|
5,822 | | ||||||||
|
Total current liabilities
|
91,765 | 82,246 | ||||||||
|
Long-term liabilities:
|
||||||||||
|
Obligations under capital leases
|
87 | 155 | ||||||||
|
Deferred revenue
|
1,711 | 1,459 | ||||||||
|
Deferred income taxes
|
2,191 | 810 | ||||||||
|
Total long-term liabilities
|
3,989 | 2,424 | ||||||||
|
Commitments and guarantees (Note 14)
|
||||||||||
|
Stockholders equity:
|
||||||||||
|
Common stock, $.05 par value
|
714 | 713 | ||||||||
|
Capital in excess of par value
|
48,083 | 47,257 | ||||||||
|
Retained earnings
|
318,289 | 324,025 | ||||||||
|
Accumulated other comprehensive income
|
28,892 | 2,141 | ||||||||
|
Unearned compensation
|
(6,341 | ) | (6,735 | ) | ||||||
|
Total stockholders equity
|
389,637 | 367,401 | ||||||||
|
Total Liabilities and Stockholders Equity
|
$ | 485,391 | $ | 452,071 | ||||||
2
| Three Months Ended | Six Months Ended | |||||||||||||||||
| January 31, | January 31, | |||||||||||||||||
| 2005 | 2004 | 2005 | 2004 | |||||||||||||||
|
Net revenue:
|
||||||||||||||||||
|
Product
|
$ | 79,201 | $ | 86,896 | $ | 155,287 | $ | 149,573 | ||||||||||
|
Engineering
|
3,169 | 4,000 | 8,409 | 10,596 | ||||||||||||||
|
Other
|
1,946 | 1,745 | 4,711 | 4,181 | ||||||||||||||
|
Total net revenue
|
84,316 | 92,641 | 168,407 | 164,350 | ||||||||||||||
|
Cost of sales:
|
||||||||||||||||||
|
Product
|
47,494 | 49,833 | 94,633 | 88,508 | ||||||||||||||
|
Engineering
|
3,480 | 2,132 | 7,542 | 4,936 | ||||||||||||||
|
Other
|
1,280 | 1,140 | 2,718 | 2,349 | ||||||||||||||
|
Total cost of sales
|
52,254 | 53,105 | 104,893 | 95,793 | ||||||||||||||
|
Gross margin
|
32,062 | 39,536 | 63,514 | 68,557 | ||||||||||||||
|
Operating expenses:
|
||||||||||||||||||
|
Research and product development
|
15,272 | 14,482 | 29,209 | 29,785 | ||||||||||||||
|
Selling and marketing
|
9,841 | 9,795 | 18,728 | 17,819 | ||||||||||||||
|
General and administrative
|
10,662 | 10,081 | 20,655 | 18,554 | ||||||||||||||
|
Asset impairment charges
|
947 | | 947 | | ||||||||||||||
|
Total operating expenses
|
36,722 | 34,358 | 69,539 | 66,158 | ||||||||||||||
|
Income (loss) from operations
|
(4,660 | ) | 5,178 | (6,025 | ) | 2,399 | ||||||||||||
|
Other (income) expense:
|
||||||||||||||||||
|
Interest income
|
(1,029 | ) | (962 | ) | (1,885 | ) | (2,086 | ) | ||||||||||
|
Interest expense
|
5 | 119 | 21 | 192 | ||||||||||||||
|
Equity (gain) loss in unconsolidated affiliates
|
356 | (158 | ) | 239 | (1 | ) | ||||||||||||
|
Other
|
12 | 101 | (580 | ) | (5 | ) | ||||||||||||
|
Total other (income) expense
|
(656 | ) | (900 | ) | (2,205 | ) | (1,900 | ) | ||||||||||
|
Income (loss) before income taxes
|
(4,004 | ) | 6,078 | (3,820 | ) | 4,299 | ||||||||||||
|
Provision (benefit) for income taxes
|
(294 | ) | 1,167 | (275 | ) | 989 | ||||||||||||
|
Net income (loss)
|
$ | (3,710 | ) | $ | 4,911 | $ | (3,545 | ) | $ | 3,310 | ||||||||
|
Net income (loss) per common share:
|
||||||||||||||||||
|
Basic
|
$ | (0.27 | ) | $ | 0.37 | $ | (0.26 | ) | $ | 0.25 | ||||||||
|
Diluted
|
(0.27 | ) | 0.37 | (0.26 | ) | 0.25 | ||||||||||||
|
Weighted average shares outstanding:
|
||||||||||||||||||
|
Basic
|
13,545 | 13,412 | 13,534 | 13,397 | ||||||||||||||
|
Diluted
|
13,545 | 13,464 | 13,534 | 13,505 | ||||||||||||||
3
| Six Months Ended | ||||||||||
| January 31, | ||||||||||
| 2005 | 2004 | |||||||||
|
OPERATING ACTIVITIES:
|
||||||||||
|
Net income (loss)
|
$ | (3,545 | ) | $ | 3,310 | |||||
|
Adjustments to reconcile net income (loss) to net cash provided
by (used for) operating activities:
|
||||||||||
|
Deferred income taxes
|
565 | 543 | ||||||||
|
Depreciation and amortization
|
10,085 | 10,508 | ||||||||
|
Allowance for doubtful accounts
|
129 | 2 | ||||||||
|
Asset impairment charges
|
947 | | ||||||||
|
Gain on sale of property, plant, and equipment
|
(1 | ) | (46 | ) | ||||||
|
Equity (gain) loss in unconsolidated affiliates
|
239 | (1 | ) | |||||||
|
Equity loss in unconsolidated affiliate classified as research
and product development expense
|
759 | 2,040 | ||||||||
|
Non-cash compensation expense from stock grants
|
1,049 | 806 | ||||||||
|
Net changes in operating assets and liabilities (Note 11)
|
3,221 | (10,875 | ) | |||||||
|
NET CASH PROVIDED BY OPERATING ACTIVITIES:
|
13,448 | 6,287 | ||||||||
|
INVESTING ACTIVITIES:
|
||||||||||
|
Investments in and advances to affiliated companies
|
(1,113 | ) | (19 | ) | ||||||
|
Acquisition of businesses, net of cash acquired
|
| (141 | ) | |||||||
|
Acquisition of assets
|
| (1,750 | ) | |||||||
|
Additions to property, plant and equipment
|
(5,562 | ) | (14,483 | ) | ||||||
|
Capitalized software
|
(3,322 | ) | (1,653 | ) | ||||||
|
Proceeds from sale of property, plant and equipment
|
34 | 156 | ||||||||
|
Maturities of marketable securities
|
10,335 | 6,485 | ||||||||
|
NET CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES
|
372 | (11,405 | ) | |||||||
|
FINANCING ACTIVITIES:
|
||||||||||
|
Payments on debt and capital lease obligations
|
(743 | ) | (1,159 | ) | ||||||
|
Issuances of stock pursuant to exercise of stock options and
employee stock purchase plan
|
172 | 1,445 | ||||||||
|
Dividends paid to shareholders
|
(2,190 | ) | (2,161 | ) | ||||||
|
NET CASH USED FOR FINANCING ACTIVITIES
|
(2,761 | ) | (1,875 | ) | ||||||
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
|
(568 | ) | 319 | |||||||
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
10,491 | (6,674 | ) | |||||||
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
149,549 | 136,806 | ||||||||
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
$ | 160,040 | $ | 130,132 | ||||||
4
| 1. | Basis of presentation: |
| 2. | Stock-based compensation: |
5
| Three Months Ended | Six Months Ended | ||||||||||||||||
| January 31, | January 31, | ||||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
|
Net income (loss), as reported
|
$ | (3,710 | ) | $ | 4,911 | $ | (3,545 | ) | $ | 3,310 | |||||||
|
Add: Stock-based employee compensation expense included in
reported net income, net of related tax effects
|
501 | 318 | 973 | 688 | |||||||||||||
|
Deduct: Stock-based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects
|
(1,241 | ) | (993 | ) | (2,440 | ) | (2,099 | ) | |||||||||
|
Pro forma net income (loss)
|
$ | (4,450 | ) | $ | 4,236 | $ | (5,012 | ) | $ | 1,899 | |||||||
|
Earnings (loss) per share:
|
|||||||||||||||||
|
Basic as reported
|
$ | (0.27 | ) | $ | 0.37 | $ | (0.26 | ) | $ | 0.25 | |||||||
|
Basic pro forma
|
(0.33 | ) | 0.32 | (0.37 | ) | 0.14 | |||||||||||
|
Diluted as reported
|
$ | (0.27 | ) | $ | 0.37 | $ | (0.26 | ) | $ | 0.25 | |||||||
|
Diluted pro forma
|
(0.33 | ) | 0.31 | (0.37 | ) | 0.14 | |||||||||||
| 3. | Balance sheet information: |
| January 31, | July 31, | ||||||||
| 2005 | 2004 | ||||||||
|
Inventories:
|
|||||||||
|
Raw materials
|
$ | 41,434 | $ | 36,246 | |||||
|
Work-in-process
|
14,968 | 12,400 | |||||||
|
Finished goods
|
13,937 | 17,306 | |||||||
| $ | 70,339 | $ | 65,952 | ||||||
|
Accrued liabilities:
|
|||||||||
|
Accrued employee compensation and benefits
|
$ | 9,923 | $ | 11,247 | |||||
|
Accrued warranty
|
5,124 | 5,039 | |||||||
|
Other
|
5,217 | 5,094 | |||||||
| $ | 20,264 | $ | 21,380 | ||||||
|
Advance payments and other:
|
|||||||||
|
Long-lead-time components
|
$ | 8,535 | $ | ||||||